|
1
|
Mou Y, Wen S, Wang Y, Zhao Y, Li YP, Sha HK, Gui LJ, Jiang ZY, Xu XM. Discovery of Novel Tofacitinib-ADTOH Molecular Hybridization Derivatives for the Treatment of Ulcerative Colitis. Antioxidants (Basel) 2025; 14:325. [PMID: 40227328 PMCID: PMC11939234 DOI: 10.3390/antiox14030325] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2025] [Revised: 02/28/2025] [Accepted: 03/03/2025] [Indexed: 04/15/2025] Open
Abstract
The treatment of ulcerative colitis (UC) has been a major medical challenge due to the lack of safe and effective drugs. Molecular hybridization is a promising strategy for the development of drugs with pleiotropic activity, which has been demonstrated in a wide range of diseases. Tofacitinib has exhibited significant effects on the remission of UC, but a series of adverse effects have occurred during its clinical application. Herein, we propose to utilize a molecular hybridization strategy to link tofacitinib with a cytoprotective H2S donor (ADTOH) to obtain a series of hybridized molecules ZX-4C~ZX-6C. Among them, ZX-4C exhibited the best performance in the H2S release rate and the cytoprotective effects against dextran sulfate sodium (DSS)-induced injury. The in vivo studies showed that ZX-4C could effectively alleviate DSS-induced colitis by enhancing oxidative stress defense and reducing the inflammatory response, demonstrating that it is more potent than the parent drugs. The data from the present study support that this molecular hybridization strategy provides a promising avenue for the treatment of UC.
Collapse
Affiliation(s)
- Yi Mou
- College of Pharmacy and Chemistry & Chemical Engineering, Taizhou University, Taizhou 225300, China; (Y.M.); (S.W.); (Y.W.); (Y.Z.); (Y.-P.L.); (H.-K.S.); (L.-J.G.)
| | - Shuai Wen
- College of Pharmacy and Chemistry & Chemical Engineering, Taizhou University, Taizhou 225300, China; (Y.M.); (S.W.); (Y.W.); (Y.Z.); (Y.-P.L.); (H.-K.S.); (L.-J.G.)
- Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China
| | - Yan Wang
- College of Pharmacy and Chemistry & Chemical Engineering, Taizhou University, Taizhou 225300, China; (Y.M.); (S.W.); (Y.W.); (Y.Z.); (Y.-P.L.); (H.-K.S.); (L.-J.G.)
| | - Yao Zhao
- College of Pharmacy and Chemistry & Chemical Engineering, Taizhou University, Taizhou 225300, China; (Y.M.); (S.W.); (Y.W.); (Y.Z.); (Y.-P.L.); (H.-K.S.); (L.-J.G.)
| | - Ying-Ping Li
- College of Pharmacy and Chemistry & Chemical Engineering, Taizhou University, Taizhou 225300, China; (Y.M.); (S.W.); (Y.W.); (Y.Z.); (Y.-P.L.); (H.-K.S.); (L.-J.G.)
| | - Hong-Kai Sha
- College of Pharmacy and Chemistry & Chemical Engineering, Taizhou University, Taizhou 225300, China; (Y.M.); (S.W.); (Y.W.); (Y.Z.); (Y.-P.L.); (H.-K.S.); (L.-J.G.)
| | - Li-Juan Gui
- College of Pharmacy and Chemistry & Chemical Engineering, Taizhou University, Taizhou 225300, China; (Y.M.); (S.W.); (Y.W.); (Y.Z.); (Y.-P.L.); (H.-K.S.); (L.-J.G.)
| | - Zheng-Yu Jiang
- Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China
| | - Xiang-Ming Xu
- College of Pharmacy and Chemistry & Chemical Engineering, Taizhou University, Taizhou 225300, China; (Y.M.); (S.W.); (Y.W.); (Y.Z.); (Y.-P.L.); (H.-K.S.); (L.-J.G.)
| |
Collapse
|
|
2
|
Discovery of small-molecule candidates against inflammatory bowel disease. Eur J Med Chem 2020; 185:111805. [DOI: 10.1016/j.ejmech.2019.111805] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/02/2019] [Revised: 10/19/2019] [Accepted: 10/20/2019] [Indexed: 12/12/2022]
|
|
3
|
Junek R, Kverka M, Jandera A, Panajotová V, Šatinský D, Macháček M, Kuchař M. Antileukotrienic phenethylamido derivatives of arylalkanoic acids in the treatment of ulcerative colitis. Eur J Med Chem 2009; 44:332-44. [DOI: 10.1016/j.ejmech.2008.02.030] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2007] [Revised: 02/15/2008] [Accepted: 02/28/2008] [Indexed: 11/26/2022]
|